← Back to all trials
Not Yet Recruiting
NCT07737613
Acute Effects of Estradiol Administration on Brain Function During Fear Learning
Conditions: PTSD and Trauma-related Symptoms, Cognitive Decline in Older Adults, Post Menopausal Women
Sex: Female
Ages: 60 Years – N/A
Healthy volunteers: Yes
Phase: EARLY_PHASE1
Enrollment: 30
Sponsor: University of Arizona
Summary
The goal of current study is to better understand how fear is processed in the brain and how these processes are influenced by cognition and hormones. This research will focus specifically on postmenopausal female adults, because age-related changes in cognition and declining estrogen levels may contribute to anxiety symptoms and PTSD risk later in life.
Eligibility Criteria
Inclusion Criteria:
* post-menopausal
* normal or corrected-to-normal vision
* English speaking
* stable medication use (no changes in the past three months)
Exclusion Criteria:
* use of hormone therapy containing synthetic estrogen
* MRI contraindications (e.g., irremovable ferrous metal in body, claustrophobia)
* history of neurological disorder (including mild cognitive impairment) or moderate to severe traumatic brain injury
* use of antipsychotic, opiate, or mood stabilizer (i.e., lithium) medication
* history of blood clots/deep vein thrombosis, prior stroke or TIA, uncontrolled hypertension
* history of migraine with aura
* severe liver disease
* history of breast, endometrial, or ovarian cancer
* smoking \>10 cigarettes/day
Source: ClinicalTrials.gov (NCT07737613). StuddyBuddy aggregates publicly available trial information.